These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12629734)

  • 1. [Hyperuricemia due to renal failure, autosomal dominant polycystic kidney disease and lead nephropathy].
    Hosoya T
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():294-8. PubMed ID: 12629734
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggravation of immunoglobulin a nephropathy by hyperuricemia: a mini-review on current findings and new concepts.
    Nasri H; Baradaran A
    Iran J Kidney Dis; 2014 Sep; 8(5):359-62. PubMed ID: 25194401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Purine metabolism in patients with renal failure].
    Hosoya T; Ohno I; Uetake D; Saikawa H
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():136-41. PubMed ID: 15250282
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hyperuricemia and gout].
    Gröbner W; Walter-Sack I
    Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gout and hyperuricemia associated with lead poisoning].
    Lejeune E; Tolot F; Meunier P
    Rev Rhum Mal Osteoartic; 1969 Apr; 36(4):161-73. PubMed ID: 5402943
    [No Abstract]   [Full Text] [Related]  

  • 6. [A comparative study of the clinicopathological features in patients with IgA nephropathy with elevated uric acid level].
    Li SH; Shi W; Xia YF; Liang XL; Wang WJ; Ma JC; Wu D
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):133-6. PubMed ID: 20118003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of sporadic medullary cystic kidney disease type 1 (MCKD1) with kidney enlargement complicated by IgA nephropathy.
    Suzuki T; Iyoda M; Yamaguchi Y; Shibata T
    Pathol Int; 2015 Jul; 65(7):379-82. PubMed ID: 25818408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricemia and gout. Classification, complications and management.
    Boss GR; Seegmiller JE
    N Engl J Med; 1979 Jun; 300(26):1459-68. PubMed ID: 221806
    [No Abstract]   [Full Text] [Related]  

  • 9. The renal allograft donor with isolated microhematuria.
    Karkar A
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):316-9. PubMed ID: 16970250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allopurinol efficacy in patients with tophus gout and chronic renal failure].
    Iakunina IA; Barskova VG; Nasonova VA
    Ter Arkh; 2006; 78(6):88-91. PubMed ID: 16881370
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperuricemia, gout and gout-induced nephropathy].
    Arkhipov VE; Borisov IA; Nasonov EL; Sura VV
    Ter Arkh; 1980; 52(4):133-42. PubMed ID: 6996182
    [No Abstract]   [Full Text] [Related]  

  • 12. Autosomal dominant polycystic kidney disease-associated glomerulonephritides.
    Ben Hmida M; Hachicha J; Jarraya F; Kharrat M; Jlidi R; Jarraya A
    Transplant Proc; 1995 Oct; 27(5):2718-9. PubMed ID: 7482888
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hyperuricemia and renal insufficiency.
    Foreman JW; Yudkoff M
    Child Nephrol Urol; 1990; 10(2):115-8. PubMed ID: 2253250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hyperuricemia and gout in CKD.
    Gaffo AL; Saag KG
    Am J Kidney Dis; 2008 Nov; 52(5):994-1009. PubMed ID: 18971014
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of autosomal dominant polycystic kidney disease and chronic glomerulonephritis.
    Todorov V; Boneva R; Minkova V
    Nephron; 1994; 67(4):502. PubMed ID: 7969695
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathophysiology and treatment of secondary hyperuricemia].
    Tsutani H
    Nihon Rinsho; 2008 Apr; 66(4):699-704. PubMed ID: 18409518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotic syndrome and IgA nephropathy in polycystic kidney disease.
    Hiura T; Yamazaki H; Saeki T; Kawabe S; Ueno M; Nishi S; Miyamura S; Gejyo F
    Clin Exp Nephrol; 2006 Jun; 10(2):136-9. PubMed ID: 16791401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.